New agreement secures 66% reduction in cost of rifapentine, which prevents ‘latent’ TB from becoming active
The price of a drug crucial to prevent tuberculosis is to be slashed by two-thirds in a deal that could stop millions from developing the disease.
TB is the leading cause of death from infectious disease worldwide, killing 1.5 million people a year, according to the latest World Health Organization (WHO) global TB report.
Continue reading...from World news | The Guardian https://ift.tt/2Pvy0Wi
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment